Not all clients with CLL have to have therapy. Even with all latest innovations, the iwCLL continue to endorses watchful observation for people with asymptomatic disease.86 This suggestion is based on not less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). 学習資料をアップロードして、すべての... https://jonahx864sbh1.sharebyblog.com/profile